Alzheimer’s Disease-Related Dementia
Early Recognition and Treatment to Improve Patient Outcomes
Case Study Accreditation and Designation of Credit Information

The Network for Continuing Medical Education (NCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.



Disclosure Policy

NCME requires that CME faculty disclose, during the planning of an acitivity, the existence of any personal financial or other relationships they or their spouses/partners have with the commercial supporter of the activity or with the manufacturer of any commercial product or service discussed in the activity.

Guest Editor:
George T. Grossberg, MD, has served as a consultant to Accera Inc., Forest Laboratories, Inc., Novartis Pharmaceuticals Corporation, Pamlabs, and Pfizer Inc, and has received honoraria from Forest Laboratories, Inc., Novartis Pharmaceuticals Corporation, and Pfizer Inc.

The NCME staff reports it has no relationships to disclose.



Learning Objectives

After taking part in this activity, participants should be able to:

  • Assess your current approach to the assessment and management of patients with mild cognitive impairment or Alzheimer’s disease in preparation for participation in the live lecture


You will need an Internet connection and Web browser to participate in this activity.




Click here to continue.